Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
High-throughput screening, traditionally the domain of big pharmaceutical companies, is now creeping into academic laboratories in the guise of chemical genomics. Though the technique can be demanding and expensive, it is already yielding impressive results, as Alan Dove finds out.